SCIENCE
May 18, 2012 | By Melissa Healy, Los Angeles Times
In an age of long commutes, late sports practices, endless workdays and 24/7 television programming, the image of Mom hanging up her dish towel at 7 p.m. and declaring "the kitchen is closed" seems a quaint relic of an earlier era. It also harks back to a thinner America. And that may be no coincidence. A new study, conducted on mice, hints at an unexpected contributor to the nation's epidemic of obesity - and, if later human studies bear it out, a possible way to have our cake and eat it too, with less risk of weight gain and the diseases that come with it. Just eat your cake - or better yet, an apple - earlier.
BUSINESS
May 17, 2012 | By Jim Puzzanghera, Los Angeles Times
WASHINGTON - Hall of Fame quarterback Joe Montana said they improved his strength and posture. Celebrity Kim Kardashian boasted they allowed her to ditch her personal trainer. But federal and state officials said the rocker-bottom Shape-ups and other toning shoes made by Skechers USA Inc. don't live up to the hype from the company and its high-profile endorsers. On Wednesday, the Manhattan Beach company agreed to pay $50 million to settle false-advertising allegations by the Federal Trade Commission and the attorneys general of 44 states, including California, as well as the District of Columbia.
HEALTH
March 30, 2009 | Judy Foreman
Manny Hamelburg, 68, a retired businessman, had fought prostate cancer for years. First, he tried radiation, then a drug with side effects that nearly killed him, and finally Lupron, a drug that blocks production of testosterone, the hormone that can fuel prostate cancer. The cancer disappeared. But life was miserable. Without normal levels of testosterone, Hamelburg says, he had no energy, and "zero libido for seven years. I was like a eunuch. I was chemically castrated. Sex was just hugs."
SCIENCE
May 22, 2012 | By Rosie Mestel, Los Angeles Times
The PSA test should be abandoned as a prostate cancer screening tool, a government advisory panel has concluded after determining that the side effects from needless biopsies and treatments hurt many more men than are potentially helped by early detection of cancers. At best, one life will be saved for every 1,000 men screened over a 10-year period, according to the U.S. Preventive Services Task Force. But 100 to 120 men will have suspicious results when there is no cancer, triggering biopsies that can carry complications such as pain, fever, bleeding, infection and hospitalization.
HEALTH
January 18, 2010 | Roy Wallack, Gear
"Oh, you mean the guy with the 70-year-old head and the 20-year-old body-builder body? That picture has got to be Photoshopped." Dr. Jeffry Life smiles when I tell him about the general reaction I get about the famous picture of him with his shirt off, the shot that turned a mild-mannered doctor in his mid-60s into a poster boy for super-fit aging and controversial hormone replacement Appearing in medical-clinic ads in airline magazines and...
NATIONAL
May 10, 2012 | By Ian Duncan, Los Angeles Times
WASHINGTON - An experimental treatment for multiple sclerosis has caused death, strokes, nerve damage and abdominal bleeding and has no proven benefits for sufferers of the disease, the Food and Drug Administration warned Thursday. Known as liberation therapy, the treatment targets chronic cerebrospinal venous insufficiency - or CCSVI - a narrowing of the veins in the head and neck. It involves inserting balloons or stents into veins to widen them in an attempt to relieve the symptoms of MS. The FDA received reports in 2011 of a patient who died from bleeding in the brain after undergoing the treatment and another who was left permanently paralyzed by a stroke.